Harsh Finechemicals Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 18-12-2024
- Paid Up Capital ₹ 1.24 M
as on 18-12-2024
- Company Age 32 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.15 M
as on 18-12-2024
- Satisfied Charges ₹ 2.00 M
as on 18-12-2024
- Revenue -85.07%
(FY 2020)
- Profit -116.91%
(FY 2020)
- Ebitda -89.78%
(FY 2020)
- Net Worth -7.56%
(FY 2020)
- Total Assets -25.06%
(FY 2020)
About Harsh Finechemicals
The Corporate was formerly known as Datta Auxo Pharma Pvt.Ltd.. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.24 M.
The company currently has active open charges totaling ₹1.15 M. The company has closed loans amounting to ₹2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Akhileshkumar Shukla and Ashwin Vira serve as directors at the Company.
- CIN/LLPIN
U99999MH1992PTC066011
- Company No.
066011
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Mar 1992
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Harsh Finechemicals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Akhileshkumar Shukla  | Additional Director | 01-Apr-2021 | Current |
| Ashwin Vira | Additional Director | 08-Aug-2016 | Current |
Financial Performance of Harsh Finechemicals.
Harsh Finechemicals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 85.07% decrease. The company also saw a substantial fall in profitability, with a 116.91% decrease in profit. The company's net worth dipped by a decrease of 7.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Harsh Finechemicals?
In 2018, Harsh Finechemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 26 Mar 1996 | ₹1.15 M | Open |
The Navjeevan Cooperative Bank Limited Creation Date: 10 Mar 2008 | ₹2.00 M | Satisfied |
How Many Employees Work at Harsh Finechemicals?
Unlock and access historical data on people associated with Harsh Finechemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Harsh Finechemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Harsh Finechemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
